GESTIÓN EN SALUD PÚBLICA: Annual Public Meeting on “Financial Transparency and Efficiency of the Prescription Drug User Fee Act, Biosimilar User Fee Act, and Generic Drug User Fee Amendments”

viernes, 5 de mayo de 2023

Annual Public Meeting on “Financial Transparency and Efficiency of the Prescription Drug User Fee Act, Biosimilar User Fee Act, and Generic Drug User Fee Amendments”

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)